ALTHE.PA
Theraclion SA [ALTHE.PA] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
ALTHE.PA Stock Summary
Top 10 Correlated ETFs
ALTHE.PA
Top 10 Correlated Stocks
ALTHE.PA
In the News
ALTHE.PA Financial details
Company Rating
Neutral
Market Cap
16.65M
Income
-8.64M
Revenue
3.05M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
30
Optionable
No
Shortable
Yes
Earnings
21 Mar 2024
P/E
-1.95
Forward P/E
-
PEG
-1.17
P/S
14.1
P/B
20.71
P/C
-
P/FCF
-3.12
Quick Ratio
1.46
Current Ratio
2.17
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.2
EPS next Y
-
EPS next Q
-
EPS this Y
-52.35%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-20.18%
Revenue last 5Y
-8.13%
Revenue Q/Q
-14.27%
EPS Q/Q
-68.23%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-42%
ROE
1593%
ROC
-0.73%
Gross Margin
-314%
Oper. Margin
-568%
Profit Margin
-469%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.3-0.848
52W High
-
52W Low
-
RSI
40
Rel Volume
1.44
Avg Volume
25.8K
Volume
37.03K
Perf Week
-5.74%
Perf Month
-3.63%
Perf Quarter
-26.91%
Perf Half Y
-37.95%
-
-
-
-
Beta
0.055
-
-
Volatility
0.01%, 0.02%
Prev Close
-6.76%
Price
0.345
Change
-6.76%
ALTHE.PA Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
| Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0.18 | 0.05 | 0.07 | 0.04 | 0 | |
| Net income per share | -0.25 | -0.24 | -0.17 | -0.17 | 0 | |
| Operating cash flow per share | -0.24 | -0.21 | -0.17 | -0.18 | 0 | |
| Free cash flow per share | -0.25 | -0.21 | -0.18 | -0.19 | 0 | |
| Cash per share | 0.09 | 0.15 | 0.11 | 0.09 | 0 | |
| Book value per share | -0.01 | -0.2 | -0.06 | 0.02 | 0 | |
| Tangible book value per share | -0.07 | 0.34 | 0.37 | -0.01 | 0 | |
| Share holders equity per share | -0.01 | -0.2 | -0.06 | 0.02 | 0 | |
| Interest debt per share | 0.43 | 0.27 | 0.11 | 0.31 | 0 | |
| Market cap | 25.16M | 32.68M | 29.83M | 26.57M | 0 | |
| Enterprise value | 24.18M | 34.42M | 29.73M | 26.59M | 0 | |
| P/E ratio | -6.63 | -8.37 | -7.93 | -5.35 | 0 | |
| Price to sales ratio | 9.04 | 43.93 | 20.14 | 21.5 | 0 | |
| POCF ratio | -6.81 | -9.84 | -7.68 | -5.04 | 0 | |
| PFCF ratio | -6.58 | -9.46 | -7.4 | -4.75 | 0 | |
| P/B Ratio | -315.54 | -10.09 | -23.44 | 48.76 | 0 | |
| PTB ratio | -315.54 | -10.09 | -23.44 | 48.76 | 0 | |
| EV to sales | 8.69 | 46.27 | 20.07 | 21.52 | 0 | |
| Enterprise value over EBITDA | -5.4 | -8.3 | -6.75 | -4.31 | 0 | |
| EV to operating cash flow | -6.55 | -10.36 | -7.65 | -5.05 | 0 | |
| EV to free cash flow | -6.32 | -9.96 | -7.37 | -4.76 | 0 | |
| Earnings yield | -0.15 | -0.12 | -0.13 | -0.19 | 0 | |
| Free cash flow yield | -0.15 | -0.11 | -0.14 | -0.21 | 0 | |
| Debt to equity | -80.3 | -1.26 | -1.88 | 16.6 | 0 | |
| Debt to assets | 0.61 | 0.39 | 0.2 | 0.65 | 0 | |
| Net debt to EBITDA | 0.22 | -0.42 | 0.02 | 0 | 0 | |
| Current ratio | 1.86 | 3.18 | 2.48 | 2.4 | 0 | |
| Interest coverage | -20.46 | -12.99 | -34.83 | -143.17 | 0 | |
| Income quality | 0.97 | 0.85 | 1.03 | 1.06 | 0 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 1.29 | 2.82 | 2.58 | 3.48 | 0 | |
| Intangibles to total assets | 0.09 | 0.09 | 0.08 | 0.07 | 0 | |
| Capex to operating cash flow | 0.04 | 0.04 | 0.04 | 0.06 | 0 | |
| Capex to revenue | -0.05 | -0.18 | -0.1 | -0.26 | 0 | |
| Capex to depreciation | -0.58 | -0.95 | -1.13 | -2.23 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 0.17 | 1.04 | 0.46 | 0.27 | 0 | |
| ROIC | -0.54 | -4.28 | -3.42 | -0.77 | 0 | |
| Return on tangible assets | -0.4 | -0.41 | -0.35 | -0.38 | 0 | |
| Graham Net | -0.42 | 0.03 | 0.1 | -0.26 | 0 | |
| Working capital | 3.25M | 4.79M | 4.73M | 5.46M | 0 | |
| Tangible asset value | -1.01M | 5.51M | 8.48M | -417.94K | 0 | |
| Net current asset value | -3.54M | 2.91M | 5.54M | -4.05M | 0 | |
| Invested capital | -80.3 | -1.26 | -1.88 | 16.6 | 0 | |
| Average receivables | 2.14M | 2.03M | 1.31M | 1.73M | 1.11M | |
| Average payables | 1.44M | 1.2M | 989.93K | 1.35M | 865.62K | |
| Average inventory | 1.68M | 1.86M | 2.42M | 2.85M | 1.53M | |
| Days sales outstanding | 347.48 | 686.69 | 303.06 | 656.38 | 0 | |
| Days payables outstanding | 74.75 | 80.55 | 59.14 | 147.44 | 0 | |
| Days of inventory on hand | 81.97 | 176.02 | 159.96 | 260.2 | 0 | |
| Receivables turnover | 1.05 | 0.53 | 1.2 | 0.56 | 0 | |
| Payables turnover | 4.88 | 4.53 | 6.17 | 2.48 | 0 | |
| Inventory turnover | 4.45 | 2.07 | 2.28 | 1.4 | 0 | |
| ROE | 47.56 | 1.21 | 2.95 | -9.11 | 0 | |
| Capex per share | -0.01 | -0.01 | -0.01 | -0.01 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
| Metric | History | 2021-12-31 | 2022-06-30 | 2022-12-31 | 2023-06-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0 | 0.01 | 0 | 0 | 0 | |
| Net income per share | 0 | -0.09 | 0 | 0 | 0 | |
| Operating cash flow per share | 0 | -0.13 | 0 | 0 | 0 | |
| Free cash flow per share | 0 | -0.13 | 0 | 0 | 0 | |
| Cash per share | 0 | 0.17 | 0 | 0 | 0 | |
| Book value per share | 0 | 0.09 | 0 | 0 | 0 | |
| Tangible book value per share | 0 | 0.06 | 0 | 0 | 0 | |
| Share holders equity per share | 0 | 0.09 | 0 | 0 | 0 | |
| Interest debt per share | 0 | 0.1 | 0 | 0 | 0 | |
| Market cap | 0 | 32.14M | 0 | 0 | 0 | |
| Enterprise value | -99K | 30.25M | 21.14K | -6.87M | 0 | |
| P/E ratio | 0 | -3.14 | 0 | 0 | 0 | |
| Price to sales ratio | 0 | 92.75 | 0 | 0 | 0 | |
| POCF ratio | 0 | -8.79 | 0 | 0 | 0 | |
| PFCF ratio | 0 | -8.38 | 0 | 0 | 0 | |
| P/B Ratio | 0 | 11.85 | 0 | 0 | 0 | |
| PTB ratio | 0 | 11.85 | 0 | 0 | 0 | |
| EV to sales | -0.17 | 87.29 | 0.02 | -7 | 0 | |
| Enterprise value over EBITDA | 0.02 | -8.98 | -0.01 | 2.23 | 0 | |
| EV to operating cash flow | 0 | -8.28 | 0 | 4.82 | 0 | |
| EV to free cash flow | 0 | -7.89 | 0 | 4.56 | 0 | |
| Earnings yield | 0 | -0.08 | 0 | 0 | 0 | |
| Free cash flow yield | 0 | -0.12 | 0 | 0 | 0 | |
| Debt to equity | -1.88 | 1.07 | 16.6 | 0.34 | 0 | |
| Debt to assets | 0.2 | 0.19 | 0.65 | 0.11 | 0 | |
| Net debt to EBITDA | 0.02 | 0.56 | -0.01 | 2.23 | 0 | |
| Current ratio | 2.48 | 2.81 | 2.4 | 2.74 | 0 | |
| Interest coverage | 0 | -383.17 | 0 | -48.92 | 0 | |
| Income quality | 0 | 1.43 | 0 | 0.58 | 0 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 6.41 | 0 | 4.86 | 0 | 0 | |
| Intangibles to total assets | 0.08 | 0.06 | 0.07 | 0.05 | 0 | |
| Capex to operating cash flow | 0 | 0.05 | 0 | 0.06 | 0 | |
| Capex to revenue | 0 | -0.51 | 0 | -0.08 | 0 | |
| Capex to depreciation | 0 | -2.15 | 0 | -0.78 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 0 | 0.43 | 0 | 0 | 0 | |
| ROIC | -1.95 | -0.51 | -0.35 | -0.42 | 0 | |
| Return on tangible assets | -0.2 | -0.17 | -0.19 | -0.12 | 0 | |
| Graham Net | 0 | -0.14 | 0 | 0 | 0 | |
| Working capital | 4.73M | 7.38M | 5.46M | 10.38M | 0 | |
| Tangible asset value | 8.48M | 1.74M | -417.94K | 5.56M | 0 | |
| Net current asset value | 5.54M | -1.57M | -4.05M | 2.04M | 0 | |
| Invested capital | -1.88 | 1.07 | 16.6 | 0.34 | 0 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 0 | 0 | 0 | 0 | 0 | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 185.69 | 868.17 | 225.82 | 145.55 | 0 | |
| Days payables outstanding | 26.69 | 23.12 | 37.61 | 53.14 | 0 | |
| Days of inventory on hand | 72.2 | 74.46 | 66.37 | 75.06 | 0 | |
| Receivables turnover | 0.48 | 0.1 | 0.4 | 0.62 | 0 | |
| Payables turnover | 3.37 | 3.89 | 2.39 | 1.69 | 0 | |
| Inventory turnover | 1.25 | 1.21 | 1.36 | 1.2 | 0 | |
| ROE | 1.67 | -0.94 | -4.41 | -0.38 | 0 | |
| Capex per share | 0 | -0.01 | 0 | 0 | 0 |
ALTHE.PA Frequently Asked Questions
What is Theraclion SA stock symbol ?
Theraclion SA is a FR stock and trading under the symbol ALTHE.PA
What is Theraclion SA stock quote today ?
Theraclion SA stock price is $0.345 today.
Is Theraclion SA stock public?
Yes, Theraclion SA is a publicly traded company.
Company Profile
- Volume Average 25.8K
- Market Capitalization 16.65M
- Employee 30
- CEO Mr. Martin Deterre
- Headquarters Malakoff,FR
- IPO Date 2014-04-25
-
Website
https://www.theraclion.com 
Theraclion SA develops echotherapy solutions using high intensity focused ultrasound system. It offers SONOVEIN, a robotic solution for non-invasive echotherapy treatment of varicose veins; ECHOPULSE, a robotic and non-invasive solution for echotherapy treatment of thyroid nodules and breast fibroadenoma; and EPack, a disposable that is installed on the device before treatment and protects the patient's skin and optimizes the image quality. The company was founded in 2004 and is based in Malakoff, France.
